HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice.

MLA

Schlosser, Sophie, et al. “HCC Biomarkers – State of the Old and Outlook to Future Promising Biomarkers and Their Potential in Everyday Clinical Practice.” Frontiers in Oncology, vol. 12, Nov. 2022, pp. 1–22. EBSCOhost, https://doi.org/10.3389/fonc.2022.1016952.

APA

Schlosser, S., Tümen, D., Volz, B., Neumeyer, K., Egler, N., Kunst, C., Tews, H. C., Schmid, S., Kandulski, A., Müller, M., & Gülow, K. (2022). HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice. Frontiers in Oncology, 12, 1–22. https://doi.org/10.3389/fonc.2022.1016952

Chicago

Schlosser, Sophie, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, et al. 2022. “HCC Biomarkers – State of the Old and Outlook to Future Promising Biomarkers and Their Potential in Everyday Clinical Practice.” Frontiers in Oncology 12 (November): 1–22. doi:10.3389/fonc.2022.1016952.